May 17, 2019
Helen Torley is the CEO of Halozyme, which delivered a strong first quarter.
Stories this photo appears in:
BIOTECH: Co. Gets Licensing Fee From Argenx
San Diego-based Halozyme reported higher revenue and net income in first quarter results, thanks to the company’s platform technology. Looking forward, the company is heading for an inflection point.